Reference
Brouwer R, et al. Continuous effectiveness and safety after a hospital-wide switch to adalimumab biosimilar: An observational study in rheumatoid arthritis patients. Pharmacology Research and Perspectives 10: No. 6, Dec 2022. Available from: URL: http://doi.org/10.1002/prp2.1025
Rights and permissions
About this article
Cite this article
Adalimumab. Reactions Weekly 1938, 33 (2023). https://doi.org/10.1007/s40278-023-30174-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-30174-4